Analyst firms · Jefferies · MEDP
Jefferies MEDP price target and rating history
Medpace Holdings Inc. (MEDP) · Health Care
Jefferies rates Medpace Holdings Inc. (MEDP) Hold with a $515 price target, as of its latest action on Jul 7, 2026. It has published 4 rating actions on MEDP since April 2024, including 2 upgrades and 2 downgrades. Across 7 firms with a MEDP price target in the last 12 months, the median target is $522. Jefferies's $515 is 1% below that.
- Current rating
- Hold
- Price target
- $515
- Median target, all firms
- $522
- Actions on MEDP
- 4
Jefferies price target on MEDP
Every Jefferies rating on MEDP
- Jul 7, 2026
- Feb 13, 2026
- Sep 25, 2024
- Apr 23, 2024
How other firms rate MEDP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | $673 | Sep 30, 2026 |
| Robert W. Baird | Neutral | $547 | Jul 8, 2026 |
| Jefferies | Hold | $515 | Jul 7, 2026 |
| Barclays | Equal Weight | $500 | Mar 6, 2026 |
| RBC Capital Markets | Outperform | $522 | Mar 3, 2026 |
| TD Cowen | Hold | $419 | Feb 18, 2026 |
| BMO Capital Markets | Market Perform | $600 | Nov 13, 2025 |
Questions about Jefferies and MEDP
- What is Jefferies's price target for MEDP?
- Jefferies's latest stated price target for Medpace Holdings Inc. (MEDP) is $515, from its action on Jul 7, 2026.
- What is Jefferies's rating on MEDP?
- Jefferies rates MEDP Hold, a neutral rating, as of Jul 7, 2026.
- When did Jefferies last change its view on MEDP?
- On Jul 7, 2026, Jefferies downgrades to Hold from Buy, price target $515.
- How does Jefferies's MEDP target compare with other analysts?
- Across 7 firms with a MEDP price target in the last 12 months, the median target is $522. Jefferies's $515 is 1% below that.
More MEDP rating histories
All Jefferies ratingsMEDP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.